gabapentin has been researched along with Smoking Cessation in 5 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Smoking Cessation: Discontinuing the habit of SMOKING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This 6-week, randomized, open-label pilot study estimated the treatment effect size of gabapentin (n = 17) compared with bupropion SR (n = 19) for smoking cessation, thereby allowing sample size calculations for a definitive comparison study." | 9.11 | A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation. ( Crockford, D; El-Guebaly, N; Patten, S; White, WD, 2005) |
| "Gabapentin-treated participants exhibited lower abstinence rates than placebo-treated participants; however, this difference was not significant." | 6.75 | Gabapentin for smoking cessation. ( Croghan, IT; Ebbert, JO; Hays, JT; Schroeder, DR; Sood, A; Sood, R; Wyatt, KD, 2010) |
| "This 6-week, randomized, open-label pilot study estimated the treatment effect size of gabapentin (n = 17) compared with bupropion SR (n = 19) for smoking cessation, thereby allowing sample size calculations for a definitive comparison study." | 5.11 | A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation. ( Crockford, D; El-Guebaly, N; Patten, S; White, WD, 2005) |
| "Gabapentin-treated participants exhibited lower abstinence rates than placebo-treated participants; however, this difference was not significant." | 2.75 | Gabapentin for smoking cessation. ( Croghan, IT; Ebbert, JO; Hays, JT; Schroeder, DR; Sood, A; Sood, R; Wyatt, KD, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaurasia, A | 1 |
| Ishrat, S | 1 |
| Tiwari, R | 1 |
| Sood, A | 2 |
| Ebbert, JO | 2 |
| Wyatt, KD | 1 |
| Croghan, IT | 2 |
| Schroeder, DR | 2 |
| Sood, R | 2 |
| Hays, JT | 2 |
| White, WD | 1 |
| Crockford, D | 1 |
| Patten, S | 1 |
| El-Guebaly, N | 1 |
| Vander Weg, MW | 1 |
| Wong, GY | 1 |
| Myrick, H | 1 |
| Malcolm, R | 1 |
| Henderson, S | 1 |
| McCormick, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gabapentin for Smoking Abstinence[NCT00578552] | Phase 2 | 80 participants (Actual) | Interventional | 2007-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Point prevalence tobacco abstinence was adjudicated if the following conditions were met: (a) self-reported tobacco abstinence for the previous 7 days with a negative response to the question Have you used any type of tobacco, even a puff, in the past 7 days? and (b) Expired Carbon Monoxide equal or less then 8 parts per million." (NCT00578552)
Timeframe: 12 weeks following start of medication
| Intervention | participants (Number) |
|---|---|
| Placebo | 5 |
| Gabapentin - 1800 mg /Day | 4 |
| Gabapentin - 2700 mg/Day | 0 |
4 trials available for gabapentin and Smoking Cessation
| Article | Year |
|---|---|
Gabapentin for cessation of smoking and non-smoking tobacco habits in Indian population.
Topics: Gabapentin; Habits; Humans; Nicotiana; Smoking Cessation; Tobacco Use | 2021 |
Gabapentin for smoking cessation.
Topics: Adult; Amines; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Excitatory Amino Acid | 2010 |
A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation.
Topics: Adolescent; Adult; Amines; Bupropion; Cyclohexanecarboxylic Acids; Dopamine Uptake Inhibitors; Excit | 2005 |
Gabapentin for smoking cessation: a preliminary investigation of efficacy.
Topics: Adult; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; | 2007 |
1 other study available for gabapentin and Smoking Cessation
| Article | Year |
|---|---|
Gabapentin for misuse of homemade nicotine nasal spray.
Topics: Acetates; Administration, Intranasal; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapent | 2001 |